Literature DB >> 5333700

Some guidelines for heparin therapy of venous thromboembolic disease.

V Gurewich, D P Thomas, R K Stuart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5333700

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Pharmacokinetic modeling of heparin and its clinical implications.

Authors:  T J McAvoy
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

2.  Monitoring heparin therapy with the activated partial thromboplastin time.

Authors:  R K Stuart; A Michel
Journal:  Can Med Assoc J       Date:  1971-03-06       Impact factor: 8.262

Review 3.  Anticoagulants in anaesthesia.

Authors:  P J Stow; F A Burrows
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

4.  Control of heparin therapy.

Authors:  W R Pitney; J E Pettit; L Armstrong
Journal:  Br Med J       Date:  1970-10-17

5.  Laboratory control of heparin therapy.

Authors:  M J O'Shea; P T Flute; G M Pannell
Journal:  J Clin Pathol       Date:  1971-09       Impact factor: 3.411

6.  Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study.

Authors:  Y Huet; M Gouault-Heilmann; G Contant; C Brun-Buisson
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

7.  Pathogenesis and conservative management of venous thrombosis and pulmonary embolism.

Authors:  P S Hunt
Journal:  Ulster Med J       Date:  1969
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.